1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Leukemia, Acute Lymphoblastic: new trials by email Literature Review of Leukemia, Acute Lymphoblastic trials Research Report on Leukemia, Acute Lymphoblastic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy - Leukemia, Acute Lymphoblastic | Phase 3 | Recruiting | Mats Heyman | 6430 | 2020-07-13 | 2026-08-12 |
| Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) Blinatumomab, Dexamethasone, Vincrisitne - Leukemia, Acute Lymphoblastic | Phase 3 | Completed | Amgen | 111 | 2015-11-10 | 2026-06-26 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Immunoproliferative Disorders (1) · Leukemia (1) · Lymphoproliferative Disorders (1) · Neoplasms (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Neoplasms by Histologic Type (2) · Immunoproliferative Disorders (1) · Leukemia (1) · Lymphoproliferative Disorders (1) · Neoplasms (1)
blinatumomab (2) · Daunorubicin (1) · Dexamethasone (1) · Ifosfamide (1) · Imatinib Mesylate (1) · Methotrexate (1) · asparaginase erwinia chrysanthemi recombinant (1) · pegaspargase (1)
Amgen (1) · Mats Heyman (1)
Belgium (2) · Denmark (2) · France (2) · Germany (2) · Netherlands (2) · Norway (2) · Portugal (2) · Spain (2) · Sweden (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Czechia (1)
2014 (1)